These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18199658)

  • 1. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.
    Hartman AL; Bird BH; Towner JS; Antoniadou ZA; Zaki SR; Nichol ST
    J Virol; 2008 Mar; 82(6):2699-704. PubMed ID: 18199658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
    Hartman AL; Dover JE; Towner JS; Nichol ST
    J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein.
    Hartman AL; Ling L; Nichol ST; Hibberd ML
    J Virol; 2008 Jun; 82(11):5348-58. PubMed ID: 18353943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.
    Hartman AL; Towner JS; Nichol ST
    Virology; 2004 Oct; 328(2):177-84. PubMed ID: 15464838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.
    Basler CF; Mikulasova A; Martinez-Sobrido L; Paragas J; Mühlberger E; Bray M; Klenk HD; Palese P; García-Sastre A
    J Virol; 2003 Jul; 77(14):7945-56. PubMed ID: 12829834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of antigenic determinant profiles of the Ebola virus VP35 protein N-terminal region using its short recombinant fragments].
    Rudzevich TN; Ternovoĭ VA; Kazachinskaia EI; Razumov IA; Chepurnov AA; Loktev VB; Netesov SV
    Mol Gen Mikrobiol Virusol; 2003; (2):38-40, backcover. PubMed ID: 12800775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.
    Feng Z; Cerveny M; Yan Z; He B
    J Virol; 2007 Jan; 81(1):182-92. PubMed ID: 17065211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.
    Gibb TR; Bray M; Geisbert TW; Steele KE; Kell WM; Davis KJ; Jaax NK
    J Comp Pathol; 2001 Nov; 125(4):233-42. PubMed ID: 11798240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
    Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
    Wilson JA; Bray M; Bakken R; Hart MK
    Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli.
    Zinzula L; Esposito F; Mühlberger E; Trunschke M; Conrad D; Piano D; Tramontano E
    Protein Expr Purif; 2009 Jul; 66(1):113-9. PubMed ID: 19233284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.
    Miyake T; Farley CM; Neubauer BE; Beddow TP; Hoenen T; Engel DA
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
    Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
    J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evasion of interferon responses by Ebola and Marburg viruses.
    Basler CF; Amarasinghe GK
    J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.
    Jin H; Yan Z; Prabhakar BS; Feng Z; Ma Y; Verpooten D; Ganesh B; He B
    J Gen Virol; 2010 Feb; 91(Pt 2):352-61. PubMed ID: 19828757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
    Enterlein S; Warfield KL; Swenson DL; Stein DA; Smith JL; Gamble CS; Kroeker AD; Iversen PL; Bavari S; Mühlberger E
    Antimicrob Agents Chemother; 2006 Mar; 50(3):984-93. PubMed ID: 16495261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
    Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.
    Zinzula L; Esposito F; Pala D; Tramontano E
    Antiviral Res; 2012 Mar; 93(3):354-63. PubMed ID: 22289166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.
    Prins KC; Cárdenas WB; Basler CF
    J Virol; 2009 Apr; 83(7):3069-77. PubMed ID: 19153231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
    Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.